<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ITMN</title>
    <link />
    <description>Headlines for InterMune</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>After AbbVie's Humira: What Next?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1406861-after-abbvie-s-humira-what-next.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 06 May 2013 16:45:42 GMT</pubDate>
    </item>
    <item>
      <title>ITMN Crosses Above Key Moving Average Level</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11908608/1/itmn-crosses-above-key-moving-average-level.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 29 Apr 2013 16:51:00 GMT</pubDate>
    </item>
    <item>
      <title>InterMune Cuts Loss, Affirms View - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97883/intermune-cuts-loss-affirms-view.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 25 Apr 2013 11:10:01 GMT</pubDate>
    </item>
    <item>
      <title>InterMune's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1369101-intermune-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 24 Apr 2013 22:22:02 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/23/this-week-in-biotech-20/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 23 Mar 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>NICE News for InterMune - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95484/nice-news-for-intermune.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 22 Mar 2013 18:28:01 GMT</pubDate>
    </item>
    <item>
      <title>Why InterMune Shares Popped</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/21/why-intermune-shares-popped/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 21 Mar 2013 12:55:00 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Morning Market Update: Markets Tumble, Oracle Posts Downbeat Results</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/03/3436251/mid-morning-market-update-markets-tumble-oracle-posts-downbeat-results.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 21 Mar 2013 10:41:28 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Morning Market Update: Markets Tumble, Oracle Posts Downbeat Results</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/midmorning-market-update-markets-tumble-oracle-posts-downbeat-results-cm229419.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Thu, 21 Mar 2013 10:41:28 GMT</pubDate>
    </item>
    <item>
      <title>National Institute for Health and Clinical Excellence in England and Wales Recommends Esbriet for Mi</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3434986/national-institute-for-health-and-clinical-excellence-in-england-and-wales-recomm.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 21 Mar 2013 05:59:49 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks to Get on Your Watchlist</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/20/3-stocks-to-get-on-your-watchlist-26/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Mar 2013 11:35:00 GMT</pubDate>
    </item>
    <item>
      <title>This Drug Needs a Wake-Up Call</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/15/this-drug-needs-a-wake-up-call/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 15 Mar 2013 14:55:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Stifel Nicolaus Cuts PT to $17 on InterMune Following Guidance</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3358496/update-stifel-nicolaus-cuts-pt-to-17-on-intermune-follow.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 22 Feb 2013 13:20:28 GMT</pubDate>
    </item>
    <item>
      <title>Wider Loss at InterMune - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93287/wider-loss-at-intermune.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 22 Feb 2013 12:30:01 GMT</pubDate>
    </item>
    <item>
      <title>No Major Earnings Surprises, But InterMune Is Cash Rich And An Interesting Trade</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1216921-no-major-earnings-surprises-but-intermune-is-cash-rich-and-an-interesting-trade.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 22 Feb 2013 11:42:37 GMT</pubDate>
    </item>
    <item>
      <title>InterMune's CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1214521-intermune-s-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Feb 2013 23:05:07 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Under $10 Worth Buying</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/19/5-stocks-under-10-worth-buying-5/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 19 Feb 2013 12:28:00 GMT</pubDate>
    </item>
    <item>
      <title>4 Biotech Stocks On The Clock</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1202331-4-biotech-stocks-on-the-clock.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Feb 2013 09:44:36 GMT</pubDate>
    </item>
    <item>
      <title>Four Biotech Stocks On The Clock</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1202331-four-biotech-stocks-on-the-clock.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Feb 2013 09:44:36 GMT</pubDate>
    </item>
    <item>
      <title>Hedge Funds Have Bought Yelp, Charter And More</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1161611-hedge-funds-have-bought-yelp-charter-and-more.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Feb 2013 15:30:47 GMT</pubDate>
    </item>
  </channel>
</rss>
